Package 0143-9281-10

{"route": ["INTRAVENOUS"], "spl_id": "f3105bfa-50ba-4e2f-8eae-0313242d8dcf", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["1193358", "1193360", "1193362"], "spl_set_id": ["c723fd27-214c-45f6-b170-a3b807ffab07"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 BOX (0143-9281-10)  / 100 mL in 1 BAG (0143-9281-01)", "package_ndc": "0143-9281-10", "marketing_start_date": "20250208"}], "brand_name": "Levetiracetam in Sodium Chloride", "product_id": "0143-9281_f3105bfa-50ba-4e2f-8eae-0313242d8dcf", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0143-9281", "generic_name": "Levetiracetam in Sodium Chloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam in Sodium Chloride", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "5 mg/mL"}], "application_number": "ANDA211356", "marketing_category": "ANDA", "marketing_start_date": "20250208", "listing_expiration_date": "20261231"}